Compound Evidence File
#EC-2026-0078
YK-11 Raw
Filed under Raw Materials. The bureau holds 92 laboratory returns for this compound from 33 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
33 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Hubei JianxiangCASE #VI-2026-0048 | A | 4 | 10.0 | 10.0 | 10.0 | 9 Mar 2026 | 4 Jun 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 3 | 10.0 | 10.0 | 10.0 | 20 Mar 2026 | 10 Jul 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 3 | 10.0 | 10.0 | 10.0 | 3 Feb 2026 | 22 Apr 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 3 | 10.0 | 10.0 | 10.0 | 14 Mar 2026 | 6 May 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 3 | 10.0 | 9.9 | 10.0 | 14 Apr 2026 | 13 Jul 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 3 | 10.0 | 9.9 | 10.0 | 14 Feb 2026 | 27 Jun 2026 |
| Trusted PeptideCASE #VI-2026-0499 | X | 1 | 10.0 | 10.0 | 10.0 | 13 Jun 2025 | 13 Jun 2025 |
| HomopeptideCASE #VI-2026-0760 | A | 6 | 9.9 | 9.9 | 10.0 | 23 May 2026 | 23 May 2026 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 6 | 9.9 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 4 | 9.9 | 9.9 | 10.0 | 20 Dec 2025 | 6 Jul 2026 |
| BachemCASE #VI-2026-0314 | A | 4 | 9.9 | 9.9 | 10.0 | 16 Mar 2026 | 1 Jul 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 4 | 9.9 | 9.9 | 9.9 | 5 Nov 2025 | 23 Jul 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 3 | 9.9 | 9.9 | 10.0 | 21 Jan 2026 | 1 Jul 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 3 | 9.9 | 9.9 | 10.0 | 26 Mar 2026 | 27 Jun 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 2 | 9.9 | 9.9 | 9.9 | 26 Jun 2026 | 2 Jul 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 2 | 9.9 | 9.9 | 10.0 | 19 Mar 2026 | 8 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 6 | 9.0 | 8.1 | 9.7 | 23 May 2026 | 23 May 2026 |
| EHZ PeptidesCASE #VI-2026-0296 | X | 1 | 9.0 | 9.0 | 9.0 | 2 Jul 2025 | 2 Jul 2025 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 6 | 8.4 | 7.7 | 9.4 | 24 May 2026 | 24 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 5 | 8.4 | 7.7 | 9.3 | 25 May 2026 | 25 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 3 | 8.4 | 7.7 | 9.5 | 24 May 2026 | 24 May 2026 |
| Huaian Hanyou PeptideCASE #VI-2026-0297 | X | 1 | 8.2 | 8.2 | 8.2 | 16 Mar 2025 | 16 Mar 2025 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 2 | 8.1 | 7.1 | 9.2 | 24 May 2026 | 24 May 2026 |
| Shandong Nuoweiou Medical Technology CoCASE #VI-2026-0076 | X | 1 | 7.1 | 7.1 | 7.1 | 11 Jun 2025 | 11 Jun 2025 |
| Mix PeptidesCASE #VI-2026-0699 | X | 2 | 6.8 | 5.8 | 7.9 | 11 Jun 2025 | 19 Jan 2026 |
| HazelCASE #VI-2026-0392 | X | 1 | 6.5 | 6.5 | 6.5 | 14 Jan 2025 | 14 Jan 2025 |
| Qingdao VitaConin International TradingCASE #VI-2026-0504 | X | 1 | 5.9 | 5.9 | 5.9 | 6 May 2025 | 6 May 2025 |
| Royal PeptidesCASE #VI-2026-0264 | X | 2 | 5.8 | 5.4 | 6.2 | 2 Jul 2025 | 24 May 2026 |
| Xingtai Lesda TechnologyCASE #VI-2026-0381 | X | 1 | 5.7 | 5.7 | 5.7 | 13 Jun 2025 | 13 Jun 2025 |
| Richards Biotech Simply RichardsCASE #VI-2026-0307 | X | 1 | 5.2 | 5.2 | 5.2 | 24 Apr 2025 | 24 Apr 2025 |
| Loti LabsCASE #VI-2026-0171 | X | 3 | 4.1 | 3.0 | 4.9 | 24 Apr 2025 | 17 May 2026 |
| Swiss ChemsCASE #VI-2026-0030 | X | 1 | 3.2 | 3.2 | 3.2 | 3 Jul 2025 | 3 Jul 2025 |
| PRIVATECASE #VI-2026-0635 | X | 1 | 0.0 | 0.0 | 0.0 | 13 Feb 2025 | 13 Feb 2025 |
Open any subject to view the batch-level evidence for YK-11 Raw alone.